The stocks of AMBA have been given a rating of hold by brokerages working for Zacks Investment Research. The rating was increased from sell to hold in a Friday report. Currently, the company enjoys a price target set at $130 which indicates an annual growth rate of about 2.27% on the current price of the company.
The Stock Commentary on AMBA
There have been quite a few research equities that have commented on the stocks of AMBA. Roth Capital has already increased the rating of the company from neutral to buy, with a price target increased from $95 to $130. This was later published in a 13th January research report.
Rosenblatt Securities has also increased the price of the company from $82 to $100 along with a buy rating that has been fixed in a 3rd December research note. Deutsche Bank has also increased the objective price from $60 to $75, along with a rating of hold in a 17th December research note. Morgan Stanley has also gone the same way, as it increased the price target of the company from $83 to $98, along with a rating of overweight. In the end, Stifel Nicolaus also increased the price tag on AMBA from $110 to $118.
One of the investment analysts covering the company has given it a rating of sell, while five of them gave it a rating of hold. Ten other investment analysts gave the company a rating of buy. Currently, AMBA has a rating of buy, with an $87 price target.
The stocks of AMBA traded on Friday at $3.5. The moving average price of the company over 50-days has been $106.68, while the moving average price of the company over 200-days has been $73.10. The market cap of the firm has been set at $4.47 billion, with a -72.22 PE ratio, and a 1.49 beta.
